Search for Clinical Trial Results
Cytomegalic Inclusion Disease - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. Condition: Transplant Recipients With CMV Infection Date: 2014-02-14 Interventions: Biological: CMV Infection Routine follow-up (viral load, creatininaemia, neutrophil count, isolation of |
Completed |
Study Name: gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females Condition: Cytomegalovirus Infections Date: 2005-08-19 Interventions:
|
Completed |
Study Name: Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients Condition: Cytomegalovirus Infections Date: 2012-06-01 Interventions: Drug: Maribavir Tablet for oral administration |
Completed |
Study Name: Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients Condition: Cytomegalovirus Infection Date: 2008-08-05 Interventions: Drug: Single arm (ganciclovir and valganciclovir) Patients received a short induction of IV ganciclovir |
Terminated |
Study Name: Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant Condition: Cytomegalovirus Infections Date: 2005-10-17 Interventions:
|
Recruiting |
Study Name: Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy Condition: Cytomegalovirus Infections Date: 2015-10-23 Interventions: Other: Blood draw and MRI The study is observational. The treatment-plan of the underlying disease remai |
Recruiting |
Study Name: Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence Condition: Cytomegalovirus Infections Date: 2016-01-26 Interventions:
|
Completed |
Study Name: Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease Condition: Cytomegalovirus Infections Date: 2000-02-24 Interventions: Drug: SDZ MSL-109 |
Completed |
Study Name: Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants Condition:
Date: 2010-07-26 Interventions: Procedure: ultrashort heat inactivation |
Recruiting |
Study Name: CMV-CTL for the Treatment of CMV Infection After HSCT Condition:
Date: 2016-12-18 Interventions:
|